![Brian Nichols](https://investorplace.com/wp-content/uploads/userphoto/17347.jpg?20240829a)
Recent Articles
How FiOS Threatens Verizon Stock Long-Term (VZ)
By
Brian Nichols, InvestorPlace Contributor
VZ needs to act fast with FiOS before it loses its value due to competition. That would free Verizon to focus on Wireless even more.
320M Users Won’t Drive Twitter Inc Higher. But 800M Will! (TWTR)
By
Brian Nichols, InvestorPlace Contributor
Twitter stock should recover as the company monetizes its large user base and Dorsey's vision comes to life.
FTR vs. CTL: Which Is the Better Dividend Stock?
By
Brian Nichols, InvestorPlace Contributor
FTR isn't equipped to tackle the competitive broadband market, while CTL has a more favorable mix of businesses outside of wireline phones.
Why Biogen Stock Is Still A Sell (BIIB)
By
Brian Nichols, InvestorPlace Contributor
Biogen stock has fallen 30% the last six months, but BIIB could still go a lot lower as its MS franchise is challenged and other drugs fail to reach potential.
Gilead (GILD) Stock Isn’t Going Anywhere, Unless …
By
Brian Nichols, InvestorPlace Contributor
Gilead upped its product sales guidance for its HCV drugs, but sales are soon to hit a wall. Investors want management to break out its cash on something worthwhile before they bid GILD stock any higher.
![Louis Navellier's Market 360 logo](https://investorplace.com/wp-content/uploads/2021/10/lnel-logo-new-175x25-1.png)
Join Louis Navellier’s Market 360 — FREE!
Get Louis Navellier’s take on the news and events impacting the market, plus his top stock picks.